Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Net Income/ Starting Line | 25.98 | 24.61 | 22.30 | 16.50 |
Depreciation/ Depletion | 2.34 | 2.26 | 1.90 | 2.04 |
Non- Cash Items | 6.29 | 4.46 | 3.43 | 1.52 |
Changesin Working Capital | -26.48 | -14.27 | -18.22 | -0.60 |
Cashfrom Operating Activities | 8.12 | 17.05 | 9.40 | 19.45 |
Capital Expenditures | -2.55 | -2.10 | -3.05 | -1.15 |
Other Investing Cash Flow Items Total | 1.97 | 4.72 | 1.72 | -17.64 |
Cashfrom Investing Activities | -0.58 | 2.62 | -1.33 | -18.78 |
Financing Cash Flow Items | -0.25 | -0.52 | -0.34 | -0.20 |
Total Cash Dividends Paid | -6.32 | -5.50 | -4.68 | - |
Issuance( Retirement)of Stock Net | 0.00 | -14.52 | - | - |
Issuance( Retirement)of Debt Net | -0.51 | -0.51 | -0.51 | -0.51 |
Cashfrom Financing Activities | -7.08 | -21.04 | -5.53 | -0.71 |
Net Changein Cash | 0.47 | -1.37 | 2.54 | -0.04 |
Cash Interest Paid | 0.25 | 0.52 | 0.34 | 0.35 |
Cash Taxes Paid | 8.26 | 8.22 | 7.56 | 5.84 |
Jenburkt Pharmaceuticals Dividend Jenburkt Pharmaceuticals Bonus Jenburkt Pharmaceuticals News Jenburkt Pharmaceuticals AGM Jenburkt Pharmaceuticals Rights Jenburkt Pharmaceuticals Splits Jenburkt Pharmaceuticals Board Meetings Jenburkt Pharmaceuticals Key Metrics Jenburkt Pharmaceuticals Shareholdings Jenburkt Pharmaceuticals Profit Loss Jenburkt Pharmaceuticals Balance Sheet Jenburkt Pharmaceuticals Q1 Results Jenburkt Pharmaceuticals Q2 Results Jenburkt Pharmaceuticals Q3 Results Jenburkt Pharmaceuticals Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks